Production of milk-derived bioactive peptides as precursor chimeric proteins in chloroplasts of Chlamydomonas reinhardtii

Plant Cell, Tissue and Organ Culture

Volumn 113, Issue 2, 2013, Pages 217-225

  Campos Quevedo, Nohemí ^a   Rosales Mendoza, Sergio ^a   Paz Maldonado, Luz María Teresita ^a   Martínez Salgado, Luis ^a   Guevara Arauza, Juan Carlos ^a   Soria Guerra, Ruth Elena ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

Chimeric protein; Chloroplast gene expression; Nutraceutic; Transgenic

Indexed keywords

GENE EXPRESSION; MICROORGANISMS; PEPTIDES;

CHIMERIC PROTEINS; CHLAMYDOMONAS REINHARDTII; CHLOROPLAST GENE EXPRESSIONS; HYPOCHOLESTEROLEMIC ACTIVITY; NUTRACEUTIC; QUANTIFICATION ASSAYS; TOTAL SOLUBLE PROTEIN; TRANSGENICS;

DAIRIES;

CHLAMYDOMONAS REINHARDTII; SOLANUM MELONGENA;

EID: 84876195872     PISSN: 01676857     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11240-012-0261-3     Document Type: Article

References (45)

1. Agyei D, Danquah K (2011) Industrial-scale manufacturing of pharmaceutical-grade bioactive peptides. Biotechnol Adv 29: 272-277.
2. Barnes D, Franklin S, Schultz J, Henry R, Brown E, Coragliotti A, Mayfield SP (2005) Contribution of 50 and 30 untranslated regions of plastid mRNAs to the expression of Chlamydomonas reinhardtii chloroplast genes. Mol Genet Genomics 274: 625-636.
3. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
4. Chi-Tsai L, Ti-Jung K, Jei-Fu S, Ming-Ching K (1999) Characterization of the dimer-monomer equilibrium of the papaya copper/zinc superoxide dismutase and its equilibrium shift by a single aminoacid mutation. J Agric Food Chem 47: 2944-2949.
5. Daniell H, Ruiz O, Dhingra A (2004) Chloroplast genetic engineering to improve agronomic traits. In: Peña L (ed) Transgenic plants: methods and protocols, vol 286. Humana Press Inc., Totowa, pp 111-137.
6. Ellstrand NC (2001) When transgenes wander, should we worry? Plant Physiol 125: 1543-1545.
7. Farran I, Rio-Manterola F, Iniguez M, Garate S, Prieto J, Mingo-Castel AM (2008) High-density seedling expression system for the production of bioactive human cardiotrophin-1, a potential therapeutic cytokine, in transgenic tobacco chloroplasts. Plant Biotechnol J 6: 516-527.
8. Goldschmidt-Clermont M (1991) Transgenic expression of aminoglycoside adenine transferase in the chloroplast: a selectable marker for site-directed transformation of Chlamydomonas. Nucl Acids Res 19: 4083-4089.
9. Gong Y, Hu H, Gao Y, Xu X, Gao H (2011) Microalgae as platforms for production of recombinant proteins and valuable compounds: progress and prospects. J Ind Microbiol Biotechnol 38: 1879-1890.
10. Griesbeck C, Kobl I, Heitzer M (2006) Chlamydomonas reinhardtii: a protein expression system for pharmaceutical and biotechnological proteins. Mol Biotechnol 34: 213-223.
11. Hernandez-Ledesma B, Recio I, Ramos M, Amigo L (2002) Preparation of ovine and caprine β-Lg hydrolysates with ACE-inhibitory activity. Identification of active peptides from β-Lg hydrolysed with thermolysin. Int Dairy J 12: 805-812.
12. Hernandez-Ledesma B, Davalos A, Bartolome B, Amigo L (2005) Preparation of antioxidant enzymatic hydrolyzates from α-lactalbumin and β-lactoglobulin. Identification of peptides by HPLC-MS/MS. J Agric Food Chem 53: 588-593.
13. Hernandez-Ledesma B, Miguel M, Amigo L, Aleixandre MA, Recio I (2007a) Effect of simulated gastrointestinal digestion on the antihypertensive properties of β-lactoglobulin peptides. J Dairy Res 74: 336-339.
14. Hernandez-Ledesma B, Recio I, Amigo L, Bartolomé B (2007b) ACE-inhibitory and radical scavenging activity of peptides derived from β-lactoglobulin. J Agric Food Chem 55: 3392-3397.
15. Jauhar PP (2001) Genetic engineering and accelerated plant improvement: opportunities and challenges. Plant Cell Tiss Organ Cult 64: 87-89.
16. Kasai S, Yoshimura S, Ishikura K, Takaoka Y, Kobayashi K, Kato K, Shinmyo A (2003) Effect of coding regions on chloroplast gene expression in Chlamydomonas reinhardtii. J Biosci Bioeng 95: 276-282.
17. Lev GS, Huo GC, Fu XY (2003) Expression of milk-derived antihypertensive peptide in Escherichia coli. J Dairy Sci 86: 1927-1931.
18. Li GH, Le GW, Shi YH (2004) Shrestha, angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutr Res 24: 469-486.
19. Liu D, Sun HY, Zhang LJ, Li SM (2007) High-level expression of milk-derived antihypertensive peptide in Escherichia coli and its bioactivity. J Agric Food Chem 55: 5109-5112.
20. Manuell AL, Beligni MV, Elder JH, Siefker DT, Tran M, Weber A, McDonald TL, Mayfield SP (2007) Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast. Plant Biotechnol J 5: 402-412.
21. Mayfield SP, Manuell AL, Chen S, Wu J, Tran M, Siefker D, Muto M, Marin-Navarro J (2007) Chlamydomonas reinhardtii chloroplasts as protein factories. Curr Opin Biotechnol 18: 126-133.
22. McCabe MS, Klaas M, Gonzalez-Rabade N, Poage M, Badillo-Corona JA, Zhou F (2008) Plastid transformation of high-biomass tobacco variety Maryland mammoth for production of human immunodeficiency virus type 1 (HIV-1) p24 antigen. Plant Biotechnol J 6: 914-929.
23. Mullally MM, Meisel H, Fitzgerald RJ (1997) Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine β-lactoglobulin. FEBS Lett 402: 99-101.
24. Murray BA, FitzGerald RJ (2007) Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Curr Pharm Des 13: 773-791.
25. Nadai M, Bally J, Vitel M, Job C, Tissot G, Botterman J (2009) High-level expression of active human alpha1-antitrypsin in transgenic tobacco chloroplasts. Transgenic Res 18: 173-183.
26. Nagaoka S, Futamura Y, Miwa K, Awano T, Yamauchi K, Kanamaru Y, Tadashi K, Kuwata T (2001) Identification of novel hypocholesterolaemic peptides derived from bovine milk β-lactoglobulin. Biochem Biophys Res Commun 281: 11-17.
27. Pellegrini A, Dettling C, Thomas U, Hunziker P (2001) Isolation and characterization of four bactericidal domains in the bovine β-lactoglobulin. Biochim Biophys Acta 1526: 131-140.
28. Pihlanto-Leppala A (2001) Bioactive peptides derived from bovine whey proteins: opioid and ace-inhibitory peptides. Trends Food Sci Tech 11: 347-356.
29. Pihlanto-Leppala A, Rokka T, Korhonen H (1998) Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int Dairy J 8: 325-331.
30. Pihlanto-Leppala A, Koskinen P, Piilola K, Tupasela T, Coronen H (2000) Angiotensin-I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. J Dairy Res 67: 53-64.
31. Rasala BA, Muto M, Lee PA, Jager M, Cardoso RM, Behnke CA, Kirk P, Hokanson CA, Crea R, Mendez M, Mayfield SP (2010) Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii. Plant Biotechnol J 8: 719-733.
32. Rosales-Mendoza S, Paz-Maldonado LMT, Govea-Alonso DO, Korban SS (2012a) Engineering production of antihypertensive peptides in plants. Plant Cell Tiss Organ Cult. doi: 10. 1007/s11240-012-0231-9.
33. Rosales-Mendoza S, Paz-Maldonado LM, Soria-Guerra RE (2012b) Chlamydomonas reinhardtii as a viable platform for the production of recombinant proteins: current status and perspectives. Plant Cell Rep 31: 479-494.
34. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
35. Sipola M, Finckenberg P, Vapaatalo H, Pihlanto-Leppala A, Korhonen H, Korpela R, Nurminen ML (2002) α-Lactorphin and β-lactorphin improve arterial function in spontaneously hypertensive rats. Life Sci 71: 1245-1253.
36. Smacchi E, Gobbetti M (2000) Bioactive peptides in dairy products: synthesis and interaction with proteolytic enzymes. Food Microbiol 17: 129-141.
37. Specht E, Miyake-Stoner S, Mayfield S (2010) Micro-algae come of age as a platform for recombinant protein production. Biotechnol Lett 32: 1373-1383.
38. Sun M, Qian K, Su N, Chang H, Liu J, Shen G (2003) Foot-and mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast. Biotechnol Lett 25: 1087-1092.
39. Surzycki R, Greenham K, Kitayama K, Dibal F, Wagner R, Rochaix JD, Ajam T, Surzycki S (2009) Factors effecting expression of vaccines in microalgae. Biologicals 37: 133-138.
40. Teli NP, Timko MP (2004) Recent developments in the use of transgenic plants for the production of human therapeutics and biopharmaceuticals. Plant Cell Tiss Organ Cult 79: 125-145.
41. Verma D, Moghimi B, LoDuca PA, Singh HD, Hoffman BE, Herzog RW (2010) Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice. Proc Natl Acad Sci USA 107: 7101-7106.
42. Wang JP, Hu JE, Cui JZ, Bai XF, Du YG, Miyaguchi Y, Lin BC (2008) Purification and identification of a ACE inhibitory peptide from oyster proteins hydrolysate and the anti-hypertensive effect of hydrolysate in spontaneously hypertensive rats. Food Chem 111: 302-308.
43. Xu RJ (1998) Bioactive peptides in milk and their biological and health implications. Food Rev Int 14: 1-16.
44. Yamauchi R, Usui H, Yunden J, Takenaka Y, Tani F, Yoshikawa M (2003) Characterization of β-lactotensin, a bioactive peptide derived from bovine β-lactoglobulin, as a neurotensin agonist. Biosci Biotechnol Biochem 67: 940-943.
45. Zambrowicz A, Timmer M, Polanowski A, Lubec G, Trziszka T (2012) Manufacturing of peptides exhibiting biological activity. Amino Acids. doi: 10. 1007/s00726-012-1379-7.